South Florida’s Largest Brain Tumor Research Fundraiser
Lake Worth, Florida (PRWEB) February 22, 2016
Walkers, runners, volunteers, activists and survivors will gather at John Prince Park in Lake Worth on Sunday, March 6th for South Florida’s largest brain tumor research fundraiser: the 7th Annual Florida Brain Cancer 5K Run/Walk, presented by Rybovich.
Since its inception in 2010, the annual race has united thousands of attendees and raised more than $1 million for brain tumor research in the state of Florida. The Race is hosted by ABC² (Accelerate Brain Cancer Cure), a venture philanthropy nonprofit with a mission to invest in research aimed at finding the fastest possible route to a cure.
The Race is open to participants of all fitness levels and runners will have the option to be timed. Highlights include: a Survivors Tent, a Kids’ Fun Run, and a Wall of Hope and Remembrance. Awards will be given to the top runners, as well as to the top three fundraising individuals and teams. The Family Fun Zone will contain many activities for the whole family including: crafts, moon-bounces, and rock climbing. Top sponsors include: Rybovich, The Case Foundation, Genentech, Delray Medical Center and Good Samaritan.
Each year, the Race helps to bring hope and attention to the underserved brain tumor community. The need to increase research funding is more urgent than ever – today, nearly 700,000 Americans are living with a primary brain tumor diagnosis, and within the next 12 months, more than 210,000 more will be diagnosed with a primary or metastatic brain tumor.
The Race begins at John Prince Park at 8:00 a.m. on Sunday, March 6th. Online registration for the race concludes Monday, February 29th at 5pm. To register as a participant or volunteer, visit http://www.fbc5k.org.
About ABC² (Accelerate Brain Cancer Cure)
ABC² is a venture philanthropy nonprofit organization that drives cutting-edge research and treatments for brain tumors. Through strategic partnerships with medical research centers, early-stage biotechnology companies and large multi-national pharmaceutical companies ABC² has awarded more than 100 grants totaling over $20 million in brain tumor research funding to highly qualified investigators and physician-scientists from 54 institutions. For more information, please visit: http://www.abc2.org